SCHEMBL19650718

SCHEMBL19650718

Cc1cc2c(cc1C)-c1cc3ccccc3cc1C2=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.48
ATM Q13315 1/20 0.47
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
NQO2 P16083 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NQO1 P15559 1/20 0.42
POR P16435 1/20 0.42
MEN1 O00255 1/20 0.42
CDC25B P30305 1/20 0.42
KMT2A Q03164 1/20 0.42
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
NPC1 O15118 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9429592 0.98 ELANE (0.50) ELANEATMALDH1A1MAPK1NQO2
SCHEMBL686651 0.91 ELANE (0.48) ELANEATMALDH1A1MAPK1TP53
SCHEMBL10057992 0.89 ELANE (0.47) ELANEATMALDH1A1MAPK1TP53
SCHEMBL30458681 0.88 MEN1 (0.53) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL29634145 0.88 MEN1 (0.53) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL16144676 0.88 MEN1 (0.53) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL354514 0.85 MEN1 (0.56) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL29364188 0.85 MEN1 (0.56) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL30130196 0.85 MEN1 (0.56) ELANEALDH1A1MAPK1TP53HPGD
SCHEMBL9269288 0.84 ELANE (0.61) ELANEALDH1A1MAPK1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183406-A1 COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS FUJIFILM CORPORATION (JP) 2023-06-15 US disclosed
US-9994661-B2 Curable composition, cured product, optical component, lens, and compound FUJIFILM CORPORATION (JP) 2018-06-12 US disclosed
US-20170342181-A1 CURABLE COMPOSITION, CURED PRODUCT, OPTICAL COMPONENT, LENS, AND COMPOUND FUJIFILM CORPORATION (JP) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342181-A1 CURABLE COMPOSITION, CURED PRODUCT, OPTICAL COMPONENT, LENS, AND COMPOUND CRYAA, UACA, CRYAB ELANE 3730/4885ATM 390/4885ALDH1A1 424/4885
US-20230183406-A1 COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS POLR1A, RAD51, POLR2A ELANE 3873/4885ATM 1452/4885ALDH1A1 1702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.